Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

• المؤلفون الرئيسيون: Tim R. Cressey, Hannah Green, Saye Khoo, Jean Marc Treluyer, Alexandra Compagnucci, Yacine Saidi, Marc Lallemant, Diana M. Gibb, David M. Burger
• التنسيق: دورية
• منشور في: 2018
• الموضوعات: Immunology and Microbiology; Medicine
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=43249121119&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/60474

Background. The optimum strategy for stopping treatment with drugs that have different half-lives in a combination regimen to minimize the risk of selecting drug-resistant viruses remains unknown. We evaluated drug concentrations in plasma, human immunodeficiency virus (HIV) load, and development of...